Pharma

Your Article Summary

See Latest Articles

Nasdaq Stays Suspension of Trading in deCODE Stock
deCODE genetics, 04/30/09

DeCODE genetics announced that it has this evening received a letter from the Nasdaq Listing and Hearing Review Council stating that the Council has called for review the April determination of the Nasdaq Listing Qualifications Panel regarding the delisting of the company's common stock from the Nasdaq Stock Market. Pending the completion of this review the Council has also stayed the Panel's proposed suspension of trading in deCODE common stock mentioned in deCODE's 8-K filing made after the close of the market this afternoon. The company's stock will therefore continue to trade as usual on the Nasdaq Capital Market during the review process.

Today in Marketing/Media/ROI...keeping you current

Receive free subspecialty "5-minute updates" via email

Chugai Revises Corporate Advertisement for First Time in Four Years
Chugai Pharmaceutical Co., 11/25/09

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex Fully Covered Esophageal Stent
Boston Scientific, 11/24/09

Medtronic Introduces 3D Recon Service to Enhance Endovascular Treatment of Aortic Aneurysms
Medtronic, 11/20/09

 See all of Marketing/Media/ROI